PointofLaw.com
 Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  
   
 
   

FORUM

« Colo. official vs. tobacco deal | Miers as bar-defender »

October 14, 2005


Jury questioning in Humeston v. Merck

One wildcard in the Humeston v. Merck Vioxx case: Judge Higbee is permitting jurors to pose questions. The questions are written, anonymously submitted, and screened by the judge; follow-ups are not allowed. To date, the questions have been creative, sophisticated, and skeptical of both sides. One thing everyone agrees upon: the questions don't add predictive power to outside observers trying to guess how the jury will decide. But attorneys on each side can ignore the jurors' questions only at their own peril. (Heather Won Tesoriero, Barbara Martinez, and Paul Davies, "Jurors Play Lawyer in Vioxx Case, Asking Tough Questions", Wall Street Journal, Oct. 14 ($); Lisa Brennan, "Keen Questioning by Jurors Demystifies Vioxx Trial", New Jersey Law Journal, Oct. 5).

Posted by Ted Frank at 12:49 AM | TrackBack (0)



categories:
Vioxx/Drug Litigation









 

 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.